Table 7.
Anti-inflammatory activity of SAET
Groups | Dose of extract (mg/kg) p.o. | Change in paw thickness (mm) ± SD (% inhibition) | |||
---|---|---|---|---|---|
1 hour | 2 hour | 3 hour | 4 hour | ||
Carrageenan control | 1.34 ± 0.1 | 2.3 ± 0.118 | 3.64 ± 0.147 | 3.23 ± 0.161 | |
(.01 ml of 1% w/v) | |||||
Carrageenan | 200 | 1.14 ± 0.103 (14.93%) | 1.74 ± 0.217 (26.44%)a | 2.50 ± 0.106 (31.3%)a | 1.97 ± 0.115 (39.0%)a |
(0.1 ml of 1% w/v) + aqueous extract | |||||
Carrageenan | 400 | 1.00 ± 0.12 (25.6%) | 1.54 ± 0.163 (35.02%)a | 1.81 ± 0.009 (50.09%)a | 1.41 ± 0.188 (56.34%)a |
(0.1 ml of 1% w/v) + aqueous extract | |||||
Carrageenan | 10 | 0.59 ± 0.118 (55.97%)a | 0.8 ± 0.121 (66.24%)a | 1.14 ± 0.121 (68.82%)a | 0.9 ± 0.118 (72.13%)a |
(0.1 ml of 1% w/v) + diclofenac sodium |
All values are expressed as mean ± SD; P < 0.05.